318 related articles for article (PubMed ID: 21742784)
1. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment.
Wang Z; Schley G; Türkoglu G; Burzlaff N; Amann KU; Willam C; Eckardt KU; Bernhardt WM
Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784
[TBL] [Abstract][Full Text] [Related]
2. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure.
Bernhardt WM; Câmpean V; Kany S; Jürgensen JS; Weidemann A; Warnecke C; Arend M; Klaus S; Günzler V; Amann K; Willam C; Wiesener MS; Eckardt KU
J Am Soc Nephrol; 2006 Jul; 17(7):1970-8. PubMed ID: 16762988
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
Imamura R; Moriyama T; Isaka Y; Namba Y; Ichimaru N; Takahara S; Okuyama A
Transplantation; 2007 May; 83(10):1371-9. PubMed ID: 17519789
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury.
Jamadarkhana P; Chaudhary A; Chhipa L; Dubey A; Mohanan A; Gupta R; Deshpande S
Am J Nephrol; 2012; 36(3):208-18. PubMed ID: 22948183
[TBL] [Abstract][Full Text] [Related]
5. Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94.
Baek JH; Reiter CE; Manalo DJ; Buehler PW; Hider RC; Alayash AI
Biochim Biophys Acta; 2011; 1809(4-6):262-8. PubMed ID: 21558026
[TBL] [Abstract][Full Text] [Related]
6. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney.
Rosenberger C; Rosen S; Shina A; Frei U; Eckardt KU; Flippin LA; Arend M; Klaus SJ; Heyman SN
Nephrol Dial Transplant; 2008 Nov; 23(11):3472-8. PubMed ID: 18515655
[TBL] [Abstract][Full Text] [Related]
7. Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model.
Heim C; Bernhardt W; Jalilova S; Wang Z; Motsch B; Ramsperger-Gleixner M; Burzlaff N; Weyand M; Eckardt KU; Ensminger SM
Interact Cardiovasc Thorac Surg; 2016 May; 22(5):561-70. PubMed ID: 26819270
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.
Souvenir R; Flores JJ; Ostrowski RP; Manaenko A; Duris K; Tang J
Transl Stroke Res; 2014 Feb; 5(1):118-27. PubMed ID: 24323731
[TBL] [Abstract][Full Text] [Related]
9. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
[TBL] [Abstract][Full Text] [Related]
10. Transient hypoxia-inducible factor activation in rat renal ablation and reduced fibrosis with L-mimosine.
Yu X; Fang Y; Ding X; Liu H; Zhu J; Zou J; Xu X; Zhong Y
Nephrology (Carlton); 2012 Jan; 17(1):58-67. PubMed ID: 21777345
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2α-regulated nitric oxide production.
He K; Chen X; Han C; Xu L; Zhang J; Zhang M; Xia Q
Kidney Int; 2014 Feb; 85(2):276-88. PubMed ID: 24025643
[TBL] [Abstract][Full Text] [Related]
12. Prolyl-hydroxylase inhibition preserves endothelial cell function in a rat model of vascular ischemia reperfusion injury.
Barnucz E; Veres G; Hegedűs P; Klein S; Zöller R; Radovits T; Korkmaz S; Horkay F; Merkely B; Karck M; Szabó G
J Pharmacol Exp Ther; 2013 Apr; 345(1):25-31. PubMed ID: 23388095
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic preconditioning produces differential expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory enzyme HIF prolyl hydroxylase 2 in neonatal rat brain.
Jones NM; Lee EM; Brown TG; Jarrott B; Beart PM
Neurosci Lett; 2006 Aug; 404(1-2):72-7. PubMed ID: 16828226
[TBL] [Abstract][Full Text] [Related]
14. Preconditioned suppression of prolyl-hydroxylases attenuates renal injury but increases mortality in septic murine models.
Schindler K; Bondeva T; Schindler C; Claus RA; Franke S; Wolf G
Nephrol Dial Transplant; 2016 Jul; 31(7):1100-13. PubMed ID: 26908768
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
16. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
Yu X; Fang Y; Liu H; Zhu J; Zou J; Xu X; Jiang S; Ding X
Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
[TBL] [Abstract][Full Text] [Related]
17. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
Kasiganesan H; Sridharan V; Wright G
Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
[TBL] [Abstract][Full Text] [Related]
18. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
19. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
20. Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation.
Hong YA; Jung SY; Yang KJ; Im DS; Jeong KH; Park CW; Hwang HS
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]